Home › NDC Lookup › RxCUI directory › RxCUI 1857925

Maraviroc 20 MG/ML Oral Solution [Selzentry] — RxCUI 1857925

RxNorm drug concept · Semantic branded drug
RxCUI 1857925 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1857925
Official nameMaraviroc 20 MG/ML Oral Solution [Selzentry]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asSelzentry 20 MG per 1 ML Oral Solution; Selzentry 20 MG in 1 mL Oral Solution
FDA products mapped3
Package NDCs mapped3
Reported Medicaid activity (SDUD)533 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Maraviroc: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Maraviroc is not a cure. It's an antiretroviral drug that helps control HIV by blocking the virus from entering your immune cells. When taken consistently with your other HIV medic...
  • What exactly is maraviroc treating — is it a cure for HIV?
  • Maraviroc only works against a specific strain of HIV called CCR5-tropic HIV. The test — called a tropism assay — checks whether your virus uses the CCR5 doorway to enter cells. If...
  • Why did my doctor order a special test before prescribing this?
📖 Read our full Maraviroc guide →

🕸️ Concept Web — How Maraviroc 20 MG/ML Oral Solution [Selzentry] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Maraviroc 20 MG/ML Oral Solution [Selzentry] RxCUI 1857925

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Maraviroc 620216
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Selzentry 728648
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Maraviroc Oral Solution 1857920
    • Maraviroc Oral Liquid Product 1857919
    • Maraviroc Oral Product 1165075
    • Maraviroc Oral Solution [Selzentry] 1857923
    • Selzentry Oral Liquid Product 1857924
    • Selzentry Oral Product 1178366
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Maraviroc 20 MG/ML Oral Solution SCD · 1857921
  • Maraviroc 20 MG/ML SCDC · 1857918
  • Maraviroc Oral Solution SCDF · 1857920
  • Maraviroc Oral Liquid Product SCDG · 1857919
  • Maraviroc Oral Product SCDG · 1165075

Brand-Name Concepts

  • Maraviroc 20 MG/ML [Selzentry] SBDC · 1857922
  • Maraviroc Oral Solution [Selzentry] SBDF · 1857923
  • Selzentry Oral Liquid Product SBDG · 1857924
  • Selzentry Oral Product SBDG · 1178366
  • Selzentry BN · 728648

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 1857925 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
49702-0223-18 60 TABLET, FILM COATED in 1 BOTTLE (49702-223-18) SELZENTRY ViiV Healthcare Company 2011-05-16
49702-0224-18 60 TABLET, FILM COATED in 1 BOTTLE (49702-224-18) SELZENTRY ViiV Healthcare Company 2011-05-16
49702-0260-55 1 KIT in 1 CARTON (49702-260-55) * 230 mL in 1 BOTTLE SELZENTRY ViiV Healthcare Company 2020-10-30
Observed labelers: ViiV Healthcare Company (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.